GENOBIOTIX ApS
CVR 27594387 · Private limited company (ApS) · Dissolved by declaration
GENOBIOTIX ApS is a Private limited company (ApS), founded on , based in Bagsværd. The company is registered in the industry forskning og eksperimentel udvikling indenfor bioteknologi. The company is no longer active (status: dissolved by declaration). 16 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (30 Apr 2020) shows equity of DKK 11k and a net result of DKK -6,875.
Company details
- CVR number
- 27594387
- Status
- Dissolved by declaration
- Company type
- Private limited company (ApS)
- Founded
- Ceased
- Address
- Skovbrynet 57
2880 Bagsværd - Municipality
- Gladsaxe
- Industry
- Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 738k
- Employees
- 1 (2005)
- Auditor
- SØNDERUP I/S
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 16 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 41.3% |
| Current ratio | 170% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 4 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2020 | 2019 |
|---|---|---|
| Gross profit | DKK -6,875 | DKK -12k |
| Net profit | DKK -6,875 | DKK -12k |
| Equity | DKK 11k | DKK -487k |
| Total assets | DKK 26k | DKK 440 |
| Cash | DKK 565 | – |
| Short-term debt | DKK 15k | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · SØNDERUP I/S.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 May 2019 – 30 Apr 2020 | 190 | Late | |
| 1 May 2018 – 30 Apr 2019 | 147 | ||
| 1 May 2017 – 30 Apr 2018 | 161 | ||
| 1 May 2016 – 30 Apr 2017 | 169 | ||
| 1 May 2015 – 30 Apr 2016 | 166 | ||
| 1 May 2014 – 30 Apr 2015 | 166 | ||
| 1 May 2013 – 30 Apr 2014 | 173 | ||
| 1 May 2012 – 30 Apr 2013 | 175 | ||
| 1 May 2011 – 30 Apr 2012 | 176 | ||
| 1 May 2010 – 30 Apr 2011 | 170 | ||
| 1 May 2009 – 30 Apr 2010 | 167 | ||
| 1 May 2008 – 30 Apr 2009 | 154 | ||
| 1 May 2007 – 30 Apr 2008 | 154 | ||
| 1 Apr 2006 – 30 Apr 2007 | 154 | ||
| 1 Apr 2005 – 31 Mar 2006 | 172 | ||
| 23 Jan 2004 – 31 Mar 2005 | 160 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Sten Verland | ||
| Board | Sten Verland | ||
| Board | Kenn Axø Gerdes | ||
| Board | Arne Fredens | ||
| Board | Anders Løbner-Olesen | ||
| Board | Lars Stoltze | ||
| Board | Hans Ramløv | ||
| Board | Sten Verland | ||
| Board | Anders Løbner-Olesen | ||
| Owner (5%) | Hans Ramløv | ||
| Owner (5%) | Anders Løbner-Olesen | ||
| Owner (33%) | VERLAND CAPITAL ApS | ||
| Owner (10%) | Lars Stoltze | ||
| Owner (33%) | STRATEGIC VENTURE CAPITAL ApS | ||
| Owner (67%) | VERLAND CAPITAL ApS | ||
| Owner (100%) | VERLAND CAPITAL ApS | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | PARTNERSELSKABET AF 1. JULI 2012 | ||
| Auditor | ADDERE REVISION STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | SYDDANSK INNOVATION ApS | ||
| Founder | VERLAND CAPITAL ApS | ||
| Founder | Forsknings-, Uddannelses- og Digitaliseringsministeriet | ||
| Founder | Kenn Axø Gerdes | ||
| Founder | Anders Løbner-Olesen |
The CEOs' other companies
Sten Verland – 54 other companies, of which 6 bankrupt
- BELE INVEST ApS Bankrupt 27 Sep 2016
- CYTOTRACK ApS Bankrupt 18 Jan 2022
- MØLLEGAARD BREEDING CENTRE A/S Bankrupt 10 Jun 1994
- SCANDINAVIAN CLINICAL NUTRITION DENMARK A/S Bankrupt 30 Dec 2009
- STIPE Therapeutics ApS Bankrupt 3 Feb 2026
- UROMED ApS Bankrupt 16 Jul 2012
- ACE BIOSCIENCES ApS Fusioneret
- ACTION PHARMA A/S Opløst
- ACTION PHARMA AF 22. FEBRUAR 2012 A/S Opløst
- ANAPA BIOTECH A/S Active
- BIOVISION A/S Opløst
- BKG-PHARMA ApS Fusioneret
- CONTINENCE CARE ApS Active
- CULTURE SCREENING ApS Opløst
- Center for Clinical and Basic Research A/S Active
- Farum Dyreklinik ApS Active
- Farum Hundehus ApS Opløst
- GLYCOM A/S Active
- Heartcore Capital (LSV) Special Limited Partner II ApS Active
- Koncenton Ikast Birkelyst A/S Active
- MINERVAX ApS Active
- MØLLEGAARD BREEDING AND RESEARCH CENTRE A/S Fusioneret
- NEMOMED A/S Opløst
- NORDIC VACCINE A/S Opløst
- NSGENE A/S Opløst
- Neumirna Therapeutics ApS Active
- Plus Medical ApS Active
- Proxi Biotech ApS Active
- SCANBUR A/S Active
- SCANBUR CORPORATION ApS Fusioneret
Address history (1 moves)
| Skovbrynet 57, 2880 Bagsværd | |
| Forskerparken 10, 5230 Odense M |
Employees per year
Other companies at the same address
- EUROPEAN DNA LABORATORIES ApS Opløst
- SIK ApS Active
- VERLAND INVEST ApS Fusioneret
- VERLAND PROPERTIES ApS Opløst
Similar companies in Gladsaxe
- PanTarg ApS Bagsværd
- CELCORE ApS Søborg
- BioCulture Nordic ApS Søborg
- NeXXerum ApS Søborg
- Sanos Holding A/S Søborg
- ZP General Partner 3 ApS Søborg
- CBio A/S Søborg
- Cellugy ApS Søborg
- Chromologics ApS Søborg
- L Folkersen Holding ApS Kongens Lyngby
- GlycoSpot ApS Søborg
- ZP GENERAL PARTNER 2 ApS Søborg
Questions and answers about GENOBIOTIX ApS
Has GENOBIOTIX ApS gone bankrupt?
No, GENOBIOTIX ApS is not registered as bankrupt in the CVR register. Its status is: dissolved by declaration.
Who is the auditor of GENOBIOTIX ApS?
GENOBIOTIX ApS most recently used SØNDERUP I/S.
When was GENOBIOTIX ApS founded?
GENOBIOTIX ApS was founded on 23 January 2004.
What is the equity of GENOBIOTIX ApS?
Equity was DKK 11k according to the annual report for the period ending 30 April 2020.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.